Saturday, October 13, 2012

Regulating Compounding Pharmacies: Why An Increased FDA Role Shouldn’t Be Our Default Option

Patrick O’Leary has written an excellent blog post at Bill of Health addressing some of the reasons not to increase the FDA's jurisdiction in light of the meningitis outbreak.  The blog is found here.  It is a must read on the topic.
.

No comments: